Startup firm seeks clinical trials in U.S for brain surgery material
05/21/2019 10:01 PM
Taipei, May 21 (CNA) Local startup company Taiwan Biomaterial Co. (TWBM) said Tuesday it is planning to apply to the Food and Drug Administration in the United States to conduct clinical trials for its globally patented brain surgery material "Foamagen."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
AirAsia to launch 3 routes between Taiwan and Japan
03/19/2024 08:33 PM - Politics
Eswatini prime minister reaffirms ties during Tsai meet
03/19/2024 07:47 PM - Science & Tech
Smart city, net zero city expositions kick off in Taipei
03/19/2024 07:31 PM - Sports
Taiwanese paddlers move up in world table tennis rankings
03/19/2024 06:31 PM - Society
CDC reports year's 1st whooping cough, meningococcal meningitis cases
03/19/2024 06:20 PM